English

MILLENNIUM PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2008-05-12

55 filing records in this dataset, filed from 1996-06-20 to 2008-05-12. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

139 million USD

2008-03-31 · USD

Exact inputs and evidence

Revenue: 139452000 USD Source

Operating margin

1.77%

2008-03-31 · %

Exact inputs and evidence

Operating Income: 2474000 USD Source
Revenue: 139452000 USD Source

Operating cash flow

33.7 million USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 33664000 USD Source

Free cash flow

32.3 million USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 33664000 USD Source
Capital Expenditure: 1354000 USD Source

Cash and cash equivalents: 144 million USD 2008-03-31 Source
Exact value

143973000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

556 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Revenue: 113279000 USD · 2007-04-01 – 2007-06-30 Source
Revenue: 122332000 USD · 2007-07-01 – 2007-09-30 Source
Revenue: 527525000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 346335000 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 139452000 USD · 2008-01-01 – 2008-03-31 Source

Net income

36.3 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Net income: -17681000 USD · 2007-04-01 – 2007-06-30 Source
Net income: -1693000 USD · 2007-07-01 – 2007-09-30 Source
Net income: 14909000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -26152000 USD · 2007-01-01 – 2007-09-30 Source
Net income: 14626000 USD · 2008-01-01 – 2008-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-05-12.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2007-12-31
Operating income: 11 of 11 periods available· newest 2007-12-31
Net income: 11 of 11 periods available· newest 2007-12-31
Operating cash flow: 6 of 11 periods available· newest 2005-12-31
Capital expenditure: 6 of 11 periods available· newest 2005-12-31
Total assets: 8 of 11 periods available· newest 2007-12-31
liabilities: No compatible figures in this window
Current assets: 8 of 11 periods available· newest 2007-12-31
Current liabilities: 8 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+8.4%

Prior period

USD 486.83 million

2006-01-01 – 2006-12-31
Current period

USD 527.53 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

527525000 − 486830000 = 40695000 USD

486830000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
527525000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MILLENNIUM PHARMACEUTICALS INC · 2007-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Year-over-year change in Revenue: 40695000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 527525000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6691 Input fundies:Revenue: 486830000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6691
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 58.86 million

Prior period

−USD 43.95 million

2006-01-01 – 2006-12-31
Current period

USD 14.91 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

14909000 − -43953000 = 58862000 USD

-43953000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
14909000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MILLENNIUM PHARMACEUTICALS INC · 2007-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Year-over-year change in Net income: 58862000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 14909000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6912 Input fundies:NetIncome: -43953000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6912
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 527.53 million 100% of revenue
Operating costs Derived USD 551.37 million 105% of revenue
Operating income −USD 23.85 million −4.5% of revenue
Tax, interest and other Derived −USD 38.76 million −7.3% of revenue
Net income USD 14.91 million 2.8% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 190% of revenue.
2001 Operating loss: operating costs were 222% of revenue.
2002 Operating loss: operating costs were 285% of revenue.
2003 Operating loss: operating costs were 221% of revenue.
2004 Operating loss: operating costs were 165% of revenue.
2005 Operating loss: operating costs were 139% of revenue.
2006 Operating loss: operating costs were 118% of revenue.
2007 Operating loss: operating costs were 105% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	196269000	373178000 Derived	-176909000	132710000 Derived	-309619000	Unavailable	Source 2000-01-01 – 2000-12-31: 196269000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -176909000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -309619000 USD Inspect Net Income Open source
2001 2001-01-01 – 2001-12-31	246216000	547792000 Derived	-301576000	-109571000 Derived	-192005000	Unavailable	Source 2001-01-01 – 2001-12-31: 246216000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -301576000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -192005000 USD Inspect Net Income Open source
2002 2002-01-01 – 2002-12-31	353033000	1007278000 Derived	-654245000	-64052000 Derived	-590193000	Unavailable	Source 2002-01-01 – 2002-12-31: 353033000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -654245000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -590193000 USD Inspect Net Income Open source
2003 2003-01-01 – 2003-12-31	433687000	958460000 Derived	-524773000	-41086000 Derived	-483687000	-273577000 Derived	Source 2003-01-01 – 2003-12-31: 433687000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -524773000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -483687000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -221155000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 52422000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	448206000	741033000 Derived	-292827000	-40530000 Derived	-252297000	-223003000 Derived	Source 2004-01-01 – 2004-12-31: 448206000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -292827000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -252297000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -173161000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 49842000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	558308000	775207000 Derived	-216899000	-18650000 Derived	-198249000	-69315000 Derived	Source 2005-01-01 – 2005-12-31: 558308000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -216899000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -198249000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -56849000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 12466000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	486830000	573591000 Derived	-86761000	-42808000 Derived	-43953000	Unavailable	Source 2006-01-01 – 2006-12-31: 486830000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -86761000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -43953000 USD Inspect Net Income Open source
2007 2007-01-01 – 2007-12-31	527525000	551372000 Derived	-23847000	-38756000 Derived	14909000	Unavailable	Source 2007-01-01 – 2007-12-31: 527525000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -23847000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 14909000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 527.5M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	196269000	Revenue: 196269000 Open source
20012001-12-31	Revenue	246216000	Revenue: 246216000 Open source
20022002-12-31	Revenue	353033000	Revenue: 353033000 Open source
20032003-12-31	Revenue	433687000	Revenue: 433687000 Open source
20042004-12-31	Revenue	448206000	Revenue: 448206000 Open source
20052005-12-31	Revenue	558308000	Revenue: 558308000 Open source
20062006-12-31	Revenue	486830000	Revenue: 486830000 Open source
20072007-12-31	Revenue	527525000	Revenue: 527525000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

8.4% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 196269000 Open source
20012001-12-31	Year over year	25.4%	Revenue: 246216000 Open source Revenue: 196269000 Open source
20022002-12-31	Year over year	43.4%	Revenue: 353033000 Open source Revenue: 246216000 Open source
20032003-12-31	Year over year	22.8%	Revenue: 433687000 Open source Revenue: 353033000 Open source
20042004-12-31	Year over year	3.3%	Revenue: 448206000 Open source Revenue: 433687000 Open source
20052005-12-31	Year over year	24.6%	Revenue: 558308000 Open source Revenue: 448206000 Open source
20062006-12-31	Year over year	-12.8%	Revenue: 486830000 Open source Revenue: 558308000 Open source
20072007-12-31	Year over year	8.4%	Revenue: 527525000 Open source Revenue: 486830000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -4.5% 2007

Net margin 2.8% 2007

Free cash flow margin -12.4% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	-90.1%	Operating Income: -176909000 Open source Revenue: 196269000 Open source
20012001-12-31	Operating margin	-122.5%	Operating Income: -301576000 Open source Revenue: 246216000 Open source
20022002-12-31	Operating margin	-185.3%	Operating Income: -654245000 Open source Revenue: 353033000 Open source
20032003-12-31	Operating margin	-121%	Operating Income: -524773000 Open source Revenue: 433687000 Open source
20042004-12-31	Operating margin	-65.3%	Operating Income: -292827000 Open source Revenue: 448206000 Open source
20052005-12-31	Operating margin	-38.8%	Operating Income: -216899000 Open source Revenue: 558308000 Open source
20062006-12-31	Operating margin	-17.8%	Operating Income: -86761000 Open source Revenue: 486830000 Open source
20072007-12-31	Operating margin	-4.5%	Operating Income: -23847000 Open source Revenue: 527525000 Open source
20002000-12-31	Net margin	-157.8%	Net Income: -309619000 Open source Revenue: 196269000 Open source
20012001-12-31	Net margin	-78%	Net Income: -192005000 Open source Revenue: 246216000 Open source
20022002-12-31	Net margin	-167.2%	Net Income: -590193000 Open source Revenue: 353033000 Open source
20032003-12-31	Net margin	-111.5%	Net Income: -483687000 Open source Revenue: 433687000 Open source
20042004-12-31	Net margin	-56.3%	Net Income: -252297000 Open source Revenue: 448206000 Open source
20052005-12-31	Net margin	-35.5%	Net Income: -198249000 Open source Revenue: 558308000 Open source
20062006-12-31	Net margin	-9%	Net Income: -43953000 Open source Revenue: 486830000 Open source
20072007-12-31	Net margin	2.8%	Net Income: 14909000 Open source Revenue: 527525000 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 196269000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 246216000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 353033000 Open source
20032003-12-31	Free cash flow margin	-63.1%	Revenue: 433687000 Open source Operating Cash Flow: -221155000 Open source Capital Expenditure: 52422000 Open source
20042004-12-31	Free cash flow margin	-49.8%	Revenue: 448206000 Open source Operating Cash Flow: -173161000 Open source Capital Expenditure: 49842000 Open source
20052005-12-31	Free cash flow margin	-12.4%	Revenue: 558308000 Open source Operating Cash Flow: -56849000 Open source Capital Expenditure: 12466000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 486830000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 527525000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -56.8M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	Not reported	No source recorded
20012001-12-31	Operating cash flow	Not reported	No source recorded
20022002-12-31	Operating cash flow	Not reported	No source recorded
20032003-12-31	Operating cash flow	-221155000	Operating Cash Flow: -221155000 Open source
20042004-12-31	Operating cash flow	-173161000	Operating Cash Flow: -173161000 Open source
20052005-12-31	Operating cash flow	-56849000	Operating Cash Flow: -56849000 Open source
20062006-12-31	Operating cash flow	Not reported	No source recorded
20072007-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -69.3M 2005

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	Unavailable	No source recorded
20012001-12-31	Free cash flow	Unavailable	No source recorded
20022002-12-31	Free cash flow	Unavailable	No source recorded
20032003-12-31	Free cash flow	-273577000	Operating Cash Flow: -221155000 Open source Capital Expenditure: 52422000 Open source
20042004-12-31	Free cash flow	-223003000	Operating Cash Flow: -173161000 Open source Capital Expenditure: 49842000 Open source
20052005-12-31	Free cash flow	-69315000	Operating Cash Flow: -56849000 Open source Capital Expenditure: 12466000 Open source
20062006-12-31	Free cash flow	Unavailable	No source recorded
20072007-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Liabilities / assets	Not reported	Total Assets: 1811922000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 1907734000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 3997607000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 3010263000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 2757031000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 2527632000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 2751812000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 2736500000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.81× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	10.91×	Current Assets: 1485580000 Open source Current Liabilities: 136174000 Open source
20012001-12-31	Current assets / current liabilities	7.46×	Current Assets: 1514617000 Open source Current Liabilities: 203163000 Open source
20022002-12-31	Current assets / current liabilities	2.04×	Current Assets: 1938741000 Open source Current Liabilities: 949547000 Open source
20032003-12-31	Current assets / current liabilities	4.36×	Current Assets: 1114748000 Open source Current Liabilities: 255758000 Open source
20042004-12-31	Current assets / current liabilities	3.74×	Current Assets: 901612000 Open source Current Liabilities: 240861000 Open source
20052005-12-31	Current assets / current liabilities	4.5×	Current Assets: 741096000 Open source Current Liabilities: 164595000 Open source
20062006-12-31	Current assets / current liabilities	4.5×	Current Assets: 1015654000 Open source Current Liabilities: 225519000 Open source
20072007-12-31	Current assets / current liabilities	7.81×	Current Assets: 1034070000 Open source Current Liabilities: 132475000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	USD 10.34 million Exact value Exact value: 10338000 USD 1998-01-01 – 1998-12-31: 10338000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 1998-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: 10338000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10338000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-01-007626.txt#3081 The citation records this snapshot. The page link may show a newer release later.	USD 7.07 million Exact value Exact value: 7066000 USD 1998-01-01 – 1998-12-31: 7066000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MILLENNIUM PHARMACEUTICALS INC · 1998-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Operating Cash Flow: 7066000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7066000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3097 The citation records this snapshot. The page link may show a newer release later.	USD 7.59 million Exact value Exact value: 7590000 USD 1998-01-01 – 1998-12-31: 7590000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MILLENNIUM PHARMACEUTICALS INC · 1998-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Capital Expenditure: 7590000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7590000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3100 The citation records this snapshot. The page link may show a newer release later.	−USD 524,000 Calculation and evidence 7066000 − 7590000 USD Exact free cash flow: -524000 USD 1998-01-01 – 1998-12-31: 7066000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 7590000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MILLENNIUM PHARMACEUTICALS INC · 1998-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Free cash flow: -524000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7066000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3097 Input fundies:CapitalExpenditure: 7590000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3100 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 351.96 million Exact value Exact value: -351960000 USD 1999-01-01 – 1999-12-31: -351960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 1999-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -351960000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -351960000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-02-009058.txt#5644 The citation records this snapshot. The page link may show a newer release later.	USD 21.99 million Exact value Exact value: 21991000 USD 1999-01-01 – 1999-12-31: 21991000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MILLENNIUM PHARMACEUTICALS INC · 1999-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Operating Cash Flow: 21991000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21991000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3097 The citation records this snapshot. The page link may show a newer release later.	USD 21.31 million Exact value Exact value: 21311000 USD 1999-01-01 – 1999-12-31: 21311000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MILLENNIUM PHARMACEUTICALS INC · 1999-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Capital Expenditure: 21311000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21311000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3100 The citation records this snapshot. The page link may show a newer release later.	USD 680,000 Calculation and evidence 21991000 − 21311000 USD Exact free cash flow: 680000 USD 1999-01-01 – 1999-12-31: 21991000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 21311000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MILLENNIUM PHARMACEUTICALS INC · 1999-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Free cash flow: 680000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21991000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3097 Input fundies:CapitalExpenditure: 21311000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0000912057-00-008507.txt#3100 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 309.62 million Exact value Exact value: -309619000 USD 2000-01-01 – 2000-12-31: -309619000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2000-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -309619000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -309619000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-03-008098.txt#5374 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 192.01 million Exact value Exact value: -192005000 USD 2001-01-01 – 2001-12-31: -192005000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2001-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -192005000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -192005000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-04-007316.txt#5478 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 590.19 million Exact value Exact value: -590193000 USD 2002-01-01 – 2002-12-31: -590193000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2002-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -590193000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -590193000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-05-005705.txt#6053 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 483.69 million Exact value Exact value: -483687000 USD 2003-01-01 – 2003-12-31: -483687000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2003-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -483687000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -483687000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10295 The citation records this snapshot. The page link may show a newer release later.	−USD 221.16 million Exact value Exact value: -221155000 USD 2003-01-01 – 2003-12-31: -221155000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MILLENNIUM PHARMACEUTICALS INC · 2003-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Operating Cash Flow: -221155000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -221155000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10776 The citation records this snapshot. The page link may show a newer release later.	USD 52.42 million Exact value Exact value: 52422000 USD 2003-01-01 – 2003-12-31: 52422000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MILLENNIUM PHARMACEUTICALS INC · 2003-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Capital Expenditure: 52422000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52422000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10909 The citation records this snapshot. The page link may show a newer release later.	−USD 273.58 million Calculation and evidence -221155000 − 52422000 USD Exact free cash flow: -273577000 USD 2003-01-01 – 2003-12-31: -221155000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 52422000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MILLENNIUM PHARMACEUTICALS INC · 2003-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Free cash flow: -273577000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -221155000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10776 Input fundies:CapitalExpenditure: 52422000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10909 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 252.3 million Exact value Exact value: -252297000 USD 2004-01-01 – 2004-12-31: -252297000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2004-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -252297000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -252297000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-07-015552.txt#11503 The citation records this snapshot. The page link may show a newer release later.	−USD 173.16 million Exact value Exact value: -173161000 USD 2004-01-01 – 2004-12-31: -173161000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MILLENNIUM PHARMACEUTICALS INC · 2004-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Operating Cash Flow: -173161000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -173161000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10776 The citation records this snapshot. The page link may show a newer release later.	USD 49.84 million Exact value Exact value: 49842000 USD 2004-01-01 – 2004-12-31: 49842000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MILLENNIUM PHARMACEUTICALS INC · 2004-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Capital Expenditure: 49842000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49842000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10909 The citation records this snapshot. The page link may show a newer release later.	−USD 223 million Calculation and evidence -173161000 − 49842000 USD Exact free cash flow: -223003000 USD 2004-01-01 – 2004-12-31: -173161000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 49842000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MILLENNIUM PHARMACEUTICALS INC · 2004-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Free cash flow: -223003000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -173161000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10776 Input fundies:CapitalExpenditure: 49842000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10909 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 198.25 million Exact value Exact value: -198249000 USD 2005-01-01 – 2005-12-31: -198249000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2005-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -198249000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -198249000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6912 The citation records this snapshot. The page link may show a newer release later.	−USD 56.85 million Exact value Exact value: -56849000 USD 2005-01-01 – 2005-12-31: -56849000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MILLENNIUM PHARMACEUTICALS INC · 2005-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Operating Cash Flow: -56849000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56849000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10776 The citation records this snapshot. The page link may show a newer release later.	USD 12.47 million Exact value Exact value: 12466000 USD 2005-01-01 – 2005-12-31: 12466000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MILLENNIUM PHARMACEUTICALS INC · 2005-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Capital Expenditure: 12466000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12466000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10909 The citation records this snapshot. The page link may show a newer release later.	−USD 69.32 million Calculation and evidence -56849000 − 12466000 USD Exact free cash flow: -69315000 USD 2005-01-01 – 2005-12-31: -56849000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 12466000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MILLENNIUM PHARMACEUTICALS INC · 2005-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Free cash flow: -69315000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56849000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10776 Input fundies:CapitalExpenditure: 12466000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001104659-06-015064.txt#10909 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 43.95 million Exact value Exact value: -43953000 USD 2006-01-01 – 2006-12-31: -43953000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2006-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: -43953000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43953000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6912 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	USD 14.91 million Exact value Exact value: 14909000 USD 2007-01-01 – 2007-12-31: 14909000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MILLENNIUM PHARMACEUTICALS INC · 2007-12-31 MILLENNIUM PHARMACEUTICALS INC (edgar:1002637) Net Income: 14909000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:52:18Z Snapshot: 035c625b4a60b9596a50832024aa4e9f2d677d47e340ffb202d2426958ea4260 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1002637/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 14909000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1002637/0001047469-08-002055.txt#6912 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

55 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001002637, 1002637, edgar:1002637

MILLENNIUM PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation